Establishment of artemisinin combination therapy as first line treatment for combating malaria: Artemisia annua cultivation in India needed for providing sustainable supply chain of artemisinin

Current Science

Volumn 89, Issue 7, 2005, Pages 1097-1102

  Kumar, Sushil ^a   Srivastava, Suchi ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Artemisia annua; Artemisinin combination therapy; Malarial drug resistance; Plasmodium falciparum malaria; Supply chain of artemisinin

Indexed keywords

ARTEMISIA ANNUA; PLASMODIUM FALCIPARUM;

EID: 31644446290     PISSN: 00113891     EISSN: 00113891     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y. and Hay, S. I., The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 2005, 434, 214-217.
2. Alles, H. K., Mendis, K. N. and Carter, R., Malaria mortality rates in South Asia and in Africa and implications for malaria control. Parasitol. Today, 1998, 14, 369-375.
3. Hay, S. I., Guerra, C. A., Tatem, A. J., Noor, A. M. and Snow, R. W., The global distribution and population at risk of malaria: Past, present and future. Lancet Infect. Dis., 2004, 4, 327-336.
4. Murray, C. J. L. and Lopez, A. D., Mortality by cause for eight regions of the world: Global burden of disease study. Lancet, 1997, 349, 1269-1276.
5. Nabarro, D. N. and Taylor, E. M., The Roll Back Malaria campaign. Science, 1998, 280, 2067-2068.
6. WHO, Antimalarial drug combination therapy. Report of a WHO Technical Consultant, WHO/CDS/RBM/ 2001. 35, WHO, Geneva, Switzerland.
7. Attaran, A. et al., WHO, the global fund, and medical malpractice in malaria treatment. Lancet, 2004, 363, 237-240.
8. Trape, J. F., The public health impact of chloroquine resistance in Africa. Am. J.Trop. Med. Hyg. (Suppl.), 2001, 64, 12-17.
9. Olliaro, P. L. and Taylor, W. R. J., Antimalarial compounds: From bench to bedside. J. Exp. Biol., 2003, 206, 3753-3759.
10. White, N. J., Assessment of pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother., 1997, 41, 1413-1422.
11. White, N. J., Antimalarial drug resistance and combination chemotherapy. Philos. Trans. R. Soc. Lond. Ser. B., 1999, 354, 739-749.
12. Yeung, S., Pongtavornpinyo, W., Hastings, I. M., Mills, A. J. and White, N. J., Antimalarial drug resistance, artemisinin combination therapy, and the contribution of modeling to elucidating policy choices. Am. J. Trop. Med. Hyg. (Suppl.), 2004, 71, 179-186.
13. WHO, Access to antimalarial medicines: Improving the affordability and financing of artemisinin-based combination therapies. WHO document, 2003.
14. Enserink, M., Source of new hope against malaria is in short supply. Science, 2005, 307, 33.
15. Klayman, D. L., Qinghaosu (artemisinin): An antimalarial drug from China. Science, 1985, 228, 1049-1055.
16. 1H NMR spectroscopy and chemometrics. J. Pharm. Biomed. Anal., 2004, 35, 117-126.
17. Wilcox, M., Rasoanaivo, P., Sharma, V. P. and Bodekar, G., Comment on 'Randomized controlled trial of a traditional preparation of Artemisia annua L. (annual worm wood) in the treatment of malaria'. Trans. R. Soc. Trop. Med. Hyg., 2004, 98, 755-756.
18. Mueller, M. S., Runyambo, N., Wagner, I., Borrman, S., Dietz, K. and Heide, L., Randomized controlled trial of a traditional preparation of Artemisia annua L. (annual wormwood) in the treatment of malaria. Trans. R. Soc. Trop. Med. Hyg., 2004, 98, 318-321.
19. White, N. J., Delaying antimalarial drug resistance with combination therapy. Parasitologia, 1999, 41, 301-308.
20. Shuhua, X. et al., Recent investigations of arteether, a novel agent for the prevention of Schistosomiasis japonica, mansoni and haematobia. Acta Trop., 2002, 82, 175-181.
21. Kumar, T. R. S., Khanuja, S. P. S., Jain, D. C., Srivastava, S., Bhattacharya, A. K., Sharma, R. P. and Kumar, S., A simple microbiological assay for the stereospecific differentiation of α and β isomers of arteether. Phytother. Res., 2000, 14, 644-646.
22. Kumar, S. et al., Method for the use of alpha arteether as an antibacterial and anti-fungal agent. US patent 6,127,405, 2000.
23. Khanuja, S. P. S. et al., Antimicrobial composition and method for producing the same. US patent 6,423,741, 2002.
24. Srivastava, S., Bioprospecting potent plant compounds targeted to inhibit cell wall biosynthesis and DNA replication in Mycobacterium smegmatis. Ph D thesis, Devi Ahilya Vishwavidyalaya, Indore, 2002.
25. Lai, H. and Singh, N. P., Oral artemisinin prevents and delays the development of 7,12-dimethylbenz (a)anthracene (DMBA)-induced breast cancer in the rat. Cancer Lett., 2005, on-line.
26. Noori, S., Naderi, G.-A., Hassan, Z. M., Habibi, Z., Bathaie, S. Z. and Hashemi, S. M. M., Immunosuppressive activity of a molecule isolated from Artemisia annua on DTH responses compared with cycloporin A. Int. Immunol. Pharm., 2004, 4, 1301-1306.
27. Bagchi, G. D., Jain, D. C. and Kumar, S., Arteether, a potent growth inhibitor from Artemisia annua. Phytochemistry, 1997, 45, 1131-1134.
28. Jefford, C. W., Why artemisinin and certain synthetic peroxides are potent antimalarials. Implication for the mode of action. Curr. Med. Chem., 2001, 8, 1803-1826.
29. Olliaro, P. L., Haynes, R. K., Meunier, B. and Yuthavong, Y., Possible modes of action of the artemisinin-type compounds. Trends Parasitol., 2001, 17, 122-126.
30. Winstanley, P., Modern chemotherapeutic options for malaria. Lancet Infect. Dis., 2001, 1, 242-250.
31. Meshnick, S. R., Artemisinin: Mechanism of action, resistance and toxicity. Int. J. Parasitol., 2002, 32, 1655-1660.
32. Kannan, R., Sahal, D. and Chauhan, V. S., Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem. Biol., 2002, 9, 321-332.
33. Ralph, S. A. et al., Metabolic maps and functions of the Plasmodium falciparum apicoplast. Nature Rev., 2004, 2, 203-216.
34. Eckstein-Ludwig, U. et al., Artemisinins target the SERCA of Plasmodium falciparum. Nature, 2003, 424, 957-961.
35. Kumar, N. and Zheng, H., Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parsitol. Res., 1990, 76, 214-218.
36. Nosten, F. et al., Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study. Lancet, 2000, 356, 297-302.
37. Ogutu, B. R., Smoak, B. L., Nduati, R. W., Mbori-Ngacha, D. A., Mwathe, F. and Shanks, G. D., The efficacy of pyrimethamine-sulphadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children. Trans. R. Soc. Trop. Med. Hyg., 2000, 94, 83-84.
38. Omari, A. A., Preston, C. and Garner, P., Artemether-lumefantrine for treating uncomplicated falciparum malaria. Cochrane Database Syst. Rev., 2003, 2, CD003125.
39. Ringwald, P., Bickii, J. and Basco, L., Randomized trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa. Lancet, 1996, 347, 24-28.
40. van Vugt, M. et al., Artemether-lumafantrine for the treatment of multi drug-resistant falciparum malaria. Trans. R. Soc. Trop. Med. Hyg., 2000, 94, 545-548.
41. van Vugt, M. et al., Efficacy of six doses of artemether-lumafantrine (benflumetol) in multidrug resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg., 1999, 60, 936-942.
42. Denis, M. B. et al., Efficacy and safety of dihydroartemisinin- piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis., 2002, 35, 1469-1476.
43. Adjuik, M. et al., Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: A randomized, multicenter trial. Lancet, 2002, 359, 1365-1372.
44. von Seidlein, L. et al., Efficacy of artesunate plus pyramethamine- sulphodoxine for uncomplicated malaria in Gambian children: A double-blind, randomized, controlled trial. Lancet, 2000, 355, 352-357.
45. Marquino, W. et al., Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Am. J. Trop. Med. Hyg., 2003, 68, 309-317.
46. Plowe, C., Monitoring antimalarial drug resistance: Making the most of tools at hand. J. Exp. Biol., 2003, 206, 3745-3752.
47. Avery, M. A., Chang, W. K. M. and Jennings-White, C., Stereoselective total synthesis of (+)-artemisinin, the antimalarial constituent of Artemisia annua L. J. Am. Chem. Soc., 1992, 114, 974-979.
48. Yadav, J. S., Satheesh Babu, R. and Sabitha, G., Stereoselective total synthesis of (+)-artemisinin. Tetrahedron Lett., 2003, 44, 387-389.
49. Vennerstrom, J. L. et al., Identification of an antimalarial synthetic trioxalane drug development candidate. Nature, 2004, 430, 900-904.
50. Picaud, S., Olofsson, L., Brodelius, M. and Brodelius, P., Expression, purification, and characterization of recombinant amorpha-4,11-diene synthase from Artemisia annua. Arch. Biochem. Biophys., 2005, 436, 215-226.
51. Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D. and Keasling, J. D., Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnol., 2003, 21, 796-802.
52. Bertea, C. M. et al., Identification of intermediates and enzymes involved in the early steps of artemisinin biosynthesis in Artemisia annua. Planta Med., 2005, 71, 40-47.
53. Abdin, M. Z., Israr, M., Rehman, R. U. and Jain, S. K., Artemisinin, a novel antimalarial drug: Biochemical and molecular approaches for enhanced production. Planta Med., 2003, 69, 289-293.
54. Ferreira, J. F. S., Simon, J. E. and Janick, J., Artemisia annua: Botany, horticulture and pharmacology. Hortic. Rev., 1997, 19, 319-371.
55. Wallart, T. E., Pras, N., Beckman, A. C. and Quax, W. J., Seasonal variation of artemisinin and its biosynthetic precursors in plants of Artemisia annua of different geographical origin: Proof of the existence of chemotypes. Planta Med., 2000, 66, 57-62.
56. Kumar, S. et al., Method for maximization of artemisinin production by the plant Artemisia annua. US patent 6,393,763, 2002.
57. Kumar, S. et al., High yields of artemisinin by multi-harvest of Artemisia annua crops. Ind. Crops Prod., 2004, 19, 77-90.
58. Jain, D. C. et al., An improved process for the simultaneous production of artemisinin and essential oil from the plant Artemisia annua. Indian patent 188,008, 2003.
59. Kumar, S. et al., Registration of Jeevanraksha and Suraksha varieties of the antimalarial medicinal plant Artemisia annua. J. Med. Aromat. Plant Sci., 1999, 21, 47-48.
60. Jain, D. C., Bhakuni, R. S., Gupta, M. M., Sharma, R. P., Kahol, A. P., Datta, G. P. and Kumar, S., Domestication of Artemisia annua plant and development of new anti-malarial drug arteether in India. Ind. Res. Prod., 2000, 59, 1-11.
61. Gupta, S. K. et al., Morphogenetic variation for artemisinin and volatile oil in Artemisia annua. Ind. Crops Prod., 2002, 16, 217-224.
62. De Megalhaes, P. M., Pereira, B., Sartoratto, A., de Oliviera, J. and Debrunner, N., New hybrid lines of anti-malarial species Artemisia annua L. In Proceedings of the Second World Congress on Medicinal and Aromatic Plants (eds Gibreti, G. et al.), Acta Hortic., 1999, 502, 377-381.
63. Delabays, N., Simonnet, X. and Caudin, M., The genetics of artemisinin content in Artemisia annua L. and the breeding of high yielding cultivars. Curr. Med. Chem., 2001, 8, 1795-1801.
64. Kumar, S. et al., Process for isolating artemisinin from Artemisia annua. US patent 6,685,972, 2004.
65. Jain, D. C., Bhakuni, R. S., Saxena, S., Kumar, S. and Viswakarma, R. A., Process for the preparation of arteethers from dihydroartemisinin. US patent 6,346,631, 2002.
66. Jain, D. C., Bhakuni, R. S., Sharma, R. P., Kumar, S. and Datta, G. P., Process for preparation of a formulation of dihydro-artemisinin for the control of wide spectrum malaria. US patent 6,362,219, 2002.
67. Jain, D. C. et al., An improved process for the simultaneous production of artemisinin and essential oil from plant Artemisia annua. US patent 5,955,084, 1999.
68. Christen, P. and Venthey, J.-L., New trends in extraction, identification and quantification of artemisinin and its derivatives. Curr. Med. Chem., 2001, 8, 1827-1839.
69. Hao, J. Y., Han, W., Huang, S. D., Xue, B. Y. and Deng, X., Microwave-assisted extraction of artemisinin from Artemisia annua L. Sep. Purif. Technol., 2002, 28, 191-196.
70. Bhakuni, R. S., Kahol, A. P., Singh, T. and Khanuja, S. P. S., Single pot conversion of artemisinin into artesunic acid. US patent 66,77,463, 2004.
71. Bhakuni, R. S., Singh, T., Kahol, A. P., Tiwari, A., Tandon, S., and Khanuja, S. P. S., Single pot conversion of artemisinin into artemether. US patent 66,83,193, 2004.
72. Kumar, S., Srivastava, R. K., Singh, A. K., Kalra, A., Tomar, V. K. S. and Bansal, R. P., Higher yields and profits from new crop rotations permitting integration of mediculture with agriculture in Indo-Gangetic plains. Curr. Sci., 2001, 80, 563-566.
73. Singh, A. K., Srivastava, R. K., Kalra, A., Bansal, R. P., Tomar, V. K. S. and Kumar, S., Characteristics of menthol mint Mentha arvensis industrial crop production in Indo-Gangetic plains. Exp. Agric., 2003, 39, 199-207.